Journey Strategic Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Buy |
1,603
+809
| +102% | +$360K | 0.02% | 217 |
|
|
2025
Q1 | $385K | Buy |
794
+72
| +10% | +$34.9K | 0.01% | 281 |
|
|
2024
Q4 | $291K | Sell |
722
-61
| -8% | -$24.6K | 0.01% | 338 |
|
|
2024
Q3 | $364K | Buy |
783
+255
| +48% | +$119K | 0.01% | 283 |
|
|
2024
Q2 | $247K | Buy |
+528
| New | +$247K | 0.01% | 301 |
|
|
2023
Q2 | – | Sell |
-716
| Closed | -$226K | – | 269 |
|
|
2023
Q1 | $226K | Sell |
716
-234
| -25% | -$73.7K | 0.02% | 206 |
|
|
2022
Q4 | $274K | Buy |
950
+257
| +37% | +$74.2K | 0.03% | 154 |
|
|
2022
Q3 | $200K | Buy |
+693
| New | +$200K | 0.03% | 158 |
|